Incidence of severe COVID-19 in a Spanish cohort of 1037 patients with rheumatic diseases treated with biologics and JAK-inhibitors
Open Access
- 10 June 2020
- journal article
- letter
- Published by BMJ in Annals Of The Rheumatic Diseases
- Vol. 81 (7), e131
- https://doi.org/10.1136/annrheumdis-2020-218152
Abstract
No abstract availableKeywords
This publication has 7 references indexed in Scilit:
- Clinical characteristics and outcomes of patients with coronavirus disease 2019 (COVID-19) and rheumatic disease: a comparative cohort study from a US 'hot spot'Annals Of The Rheumatic Diseases, 2020
- Trisomy 21 and the coronavirus disease 2019 (COVID-19)Archivos Argentinos de Pediatria, 2020
- Covid-19 in Immune-Mediated Inflammatory Diseases — Case Series from New YorkThe New England Journal of Medicine, 2020
- SAT0409 BIOLOGIC TREATMENT IN PSORIATIC ARTHRITIS AND AXIAL SPONDYLOPATHY REDUCES SICKNOTES ISSUED BY GPS, DESPITE DELAYS IN DIAGNOSIS: A REAL-LIFE STUDY IN WALES.Annals Of The Rheumatic Diseases, 2020
- What is the true incidence of COVID-19 in patients with rheumatic diseases?Annals Of The Rheumatic Diseases, 2020
- Predictors of mortality for patients with COVID-19 pneumonia caused by SARS-CoV-2: a prospective cohort studyEuropean Respiratory Journal, 2020
- Clinical course of COVID-19 in a series of patients with chronic arthritis treated with immunosuppressive targeted therapiesAnnals Of The Rheumatic Diseases, 2020